Boston keratoprosthesis type 1 for herpes simplex and herpes zoster keratopathy

Cornea

Volumn 33, Issue 8, 2014, Pages 801-805

  Brown, Curtis R ^a   Wagoner, Michael D ^a   Welder, Jeffrey D ^a   Cohen, Alex W ^b   Goins, Kenneth M ^a   Greiner, Mark A ^a   Kitzmann, Anna S ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Boston keratoprosthesis type 1; herpes keratopathy; herpes simplex virus; herpes zoster virus

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; ENDOPHTHALMITIS; FEMALE; FOLLOW UP; HERPES SIMPLEX; HERPES ZOSTER; HUMAN; KERATITIS; KERATOPATHY; KERATOPROSTHESIS; MALE; MEDICAL RECORD REVIEW; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; VISUAL ACUITY; AGED; ARTIFICIAL ORGAN; BIOPROSTHESIS; COMPARATIVE STUDY; CORNEA; EYE REFRACTION; GRAFT SURVIVAL; HERPES ZOSTER OPHTHALMICUS; KERATITIS, HERPETIC; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ARTIFICIAL ORGANS; BIOPROSTHESIS; CORNEA; FEMALE; GRAFT SURVIVAL; HERPES ZOSTER OPHTHALMICUS; HUMANS; KERATITIS, HERPETIC; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; REFRACTION, OCULAR; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 84904246097     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0000000000000164     Document Type: Article

References (27)

1. Ficker LA, Kirkness CM, Rice NS, et al. Longterm prognosis for corneal grafting in herpes simplex keratitis. Eye (Lond). 1988;2:400-408
2. Tanure MA, Cohen EJ, Grewal S, et al. Penetrating keratoplasty for varicella-zoster virus keratopathy. Cornea. 2000;19:135-139. (Pubitemid 30140813
3. Garcia DD, Shtein RM, Musch DC, et al. Herpes simplex virus keratitis: Histopathologic neovascularization and corneal allograft failure. Cornea. 2009;28:963-965
4. Goodfellow JF, Nabili S, Jones MN, et al. Antiviral treatment following penetrating keratoplasty for herpetic keratitis. Eye (Lond). 2011;25:470-474
5. Ciolino JB, Belin MW, Todani A, et al. Retention of the Boston keratoprosthesis type 1: Multicenter study results. Ophthalmology. 2013;120: 1195-1200
6. Muñoz-Gutierrez G, Alvarez de Toledo J, Barraquer RI, et al. Post-surgical visual outcome and complications in Boston type 1 keratoprosthesis. Arch Soc Esp Oftalmol. 2013;88:56-63
7. Aldave AJ, Sangwan VS, Basu S, et al. International results with the Boston type I keratoprosthesis. Ophthalmology. 2012;119:1530-1538
8. Patel AP, Wu EI, Ritterband DC, et al. Boston type 1 keratoprosthesis: The New York Eye and Ear experience. Eye (Lond). 2012;26:418-425
9. Greiner MA, Li JY, Mannis MJ. Longer-Term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis. Ophthalmology. 2011;118:1543-1550
10. Colby KA, Koo EB. Expanding indications for the Boston keratoprosthesis. Curr Opin Ophthalmol. 2011;22:267-273
11. Robert MC, Harissi-Dagher M. Boston type 1 keratoprosthesis: The CHUM experience. Can J Ophthalmol. 2011;46:164-168
12. Aldave AJ, Kamal KM, Vo RC, et al. The Boston type I keratoprosthesis: Improving outcomes and expanding indications. Ophthalmology. 2009; 116:640-651
13. Harissi-Dagher M, Dohlman CH. The Boston Keratoprosthesis in severe ocular trauma. Can J Ophthalmol. 2008;43:165-169
14. Khan BF, Harissi-Dagher M, Khan DM, et al. Advances in Boston keratoprosthesis: Enhancing retention and prevention of infection and inflammation. Int Ophthalmol Clin. 2007;47:61-71
15. Yaghouti F, Nouri M, Abad JC, et al. Keratoprosthesis: Preoperative prognostic categories. Cornea. 2001;20:19-23
16. Todani A, Gupta P, Colby K, et al. Type I Boston keratoprosthesis with cataract extraction and intraocular lens placement for visual rehabilitation of herpes zoster ophthalmicus: The "KPro Triple". Br J Ophthalmol. 2009;93:119
17. Pavan-Langston D, Dohlman CH. Boston keratoprosthesis treatment of herpes zoster neurotrophic keratopathy. Ophthalmology. 2008;115(2 suppl): S21-S23
18. Khan BF, Harissi-Dagher M, Pavan-Langston D, et al. The Boston keratoprosthesis in herpetic keratitis. Arch Ophthalmol. 2007;125: 745-749. (Pubitemid 46919734
19. Bradley JC, Hernandez EG, Schwab IR, et al. Boston type 1 keratoprosthesis: The university of california davis experience. Cornea. 2009;28: 321-327
20. Zerbe BL, Belin MW, Ciolino JB; Boston Type 1 Keratoprosthesis Study Group. Results from the multicenter Boston Type 1 Keratoprosthesis Study. Ophthalmology. 2006;113:1779.e1-e7
21. Aquavella JV, Qian Y, McCormick GJ, et al. Keratoprosthesis: The Dohlman-Doane device. Am J Ophthalmol. 2005;140:1032-1038
22. Birkholz ES, Goins KM. Boston keratoprosthesis: An option for patients with multiple failed corneal grafts. 2012. University of Iowa Health Care Web site. Available at: Http://webeye.ophth.uiowa.edu/eyeforum/cases/ 94-Boston-Keratoprosthesis-Failed-Corneal-Grafts.htm. Accessed April 1, 2014
23. Wandling GR Jr, Rauen MP, Goins KM, et al. Glaucoma therapy escalation in eyes with pseudophakic corneal edema after penetrating keratoplasty and Descemet's stripping automated endothelial keratoplasty. Int Ophthalmol. 2012;32:9-14
24. Wandling GR Jr, Parikh M, Robinson C, et al. Escalation of glaucoma therapy after deep lamellar endothelial keratoplasty. Cornea. 2010;29: 991-995
25. Dohlman CH, Dudenhoefer EJ, Khan BF, et al. Protection of the ocular surface after keratoprosthesis surgery: The role of soft contact lenses. CLAO J. 2002;28:72-74. (Pubitemid 41646458
26. Magalhães FP, do Nascimento HM, Ecker DJ, et al. Microbiota evaluation of patients with a Boston type I keratoprosthesis treated with topical 0.5% moxifloxacin and 5% povidone-iodine. Cornea. 2013;32:407-411
27. Barnes SD, Dohlman CH, Durand ML. Fungal colonization and infection in Boston keratoprosthesis. Cornea. 2007;26:9-15. (Pubitemid 46041557